Concepedia
Statistics
Publications
3
Citations
141
H-Index
Active since
2023
Affiliations
Zhongnan Hospital of Wuhan University(Current)
Wuhan University
Southern University of Science and Technology
Henan University
Army Medical University
Shu Xi is an author at Zhongnan Hospital of Wuhan University specializing in molecular oncology, oncology, and cancer cell signaling.
Publications per year
2023–2023
YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer
Shuai Yuan, Shu Xi, Hong Weng et al. · Cell Death and Differentiation · 2023 · 79 citations · Full text
Medicine, Molecular Biology, Oncology +11
A potassium-chloride co-transporter promotes tumor progression and castration resistance of prostate cancer through m6A reader YTHDC1
Shuai Yuan, Shaohua He, Luyao Li et al. · Cell Death and Disease · 2023 · 43 citations · Full text
Medicine, Molecular Biology, Oncology +8
Downregulation of N6-methyladenosine-modified LINC00641 promotes EMT, but provides a ferroptotic vulnerability in lung cancer
Shu Xi, Dao‐Jing Ming, Jinhui Zhang et al. · Cell Death and Disease · 2023 · 19 citations · Full text
Medicine, Molecular Biology, Oncology +14
1–3 of 3